STIMULATE-ICP (Symptoms, Trajectory, Inequalities and Management: Understanding Long-COVID to Address and Transform Existing Integrated Care Pathways)

  • Funded by Department of Health and Social Care / National Institute for Health and Care Research (DHSC-NIHR)
  • Total publications:0 publications
Grant search

Key facts

  • Disease

    COVID-19
  • Known Financial Commitments (USD)

    $9,357,480
  • Funder

    Department of Health and Social Care / National Institute for Health and Care Research (DHSC-NIHR)
  • Principal Investigator

    Professor Amitava Bannerjee
  • Research Location

    United Kingdom
  • Lead Research Institution

    University College London Hospitals NHS Trust
  • Research Priority Alignment

    N/A
  • Research Category

    Clinical characterisation and management

  • Research Subcategory

    Disease pathogenesis

  • Special Interest Tags

    N/A

  • Study Type

    Clinical

  • Clinical Trial Details

    Unspecified

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

Developed with the help of patient organisations, this project will test the efficacy of existing drugs to treat long COVID, and measure the different effects of three months' treatment on patients with regards to their symptoms, mental health and other outcomes such as returning to work. It will also assess the use of MRI scans to help diagnose potential organ damage in those recovering from the coronavirus, as well as enhanced rehabilitation - the provision of joined-up specialist care centred around an app for patients allowing them to track their symptoms.